Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Acute Kidney Injury
NCT02951299Phase 3Unknown
- Sponsor
- Taipei Medical University Hospital
- Start
- May 2017
- Primary completion
- Jun 2017
- Modality
- Small Molecules
01
Overview
Phase 3, open-label trial of pentoxifylline in acute kidney injury (AKI) (2 arms), sponsored by Taipei Medical University Hospital. Primary endpoint: Renal outcome at 4 weeks. Status: unknown.
02
Drugs
pentoxifylline
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02951299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02951299.